Literature DB >> 8851885

Identification of a novel protein, DMAP, which interacts with the myotonic dystrophy protein kinase and shows strong homology to D1 snRNP.

Y H Fu1.   

Abstract

The most common adult form of muscular dystrophy, myotonic dystrophy, is due to a triplet repeat (CTG) expansion in the 3' untranslated region of the myotonic dystrophy gene. Although this gene is known to encode a protein kinase, the mechanism by which a defect in this gene results in a disease state is not understood. To gain insight into this mechanism, the yeast two hybrid system was utilized to identify proteins which interact with myotonic dystrophy protein kinase. Eight positive clones were identified that interact specifically with the myotonic dystrophy protein kinase. One clone, which encodes a novel protein interacting with myotonic dystrophy protein kinase both in vivo in yeast and in vitro, was characterized further. The gene encoding this protein may represent a member of a small gene family, and the protein (95 amino acids) exhibits a high degree of homology to an snRNP protein, D1. This novel protein may be a member of the signal transduction pathway which is responsible for the manifestation of this disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851885     DOI: 10.1007/bf00132588

Source DB:  PubMed          Journal:  Genetica        ISSN: 0016-6707            Impact factor:   1.082


  22 in total

1.  A protein kinase substrate identified by the two-hybrid system.

Authors:  X Yang; E J Hubbard; M Carlson
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

2.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

3.  Molecular cloning of a cDNA encoding the human Sm-D autoantigen.

Authors:  L A Rokeach; J A Haselby; S O Hoch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  A comparative electron spin resonance study of the erythrocyte membrane in myotonic muscular dystrophy.

Authors:  D A Butterfield; A D Roses; M L Cooper; S H Appel; D B Chesnut
Journal:  Biochemistry       Date:  1974-12-03       Impact factor: 3.162

5.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Authors:  T Durfee; K Becherer; P L Chen; S H Yeh; Y Yang; A E Kilburn; W H Lee; S J Elledge
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

6.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.

Authors:  H T Orr; M Y Chung; S Banfi; T J Kwiatkowski; A Servadio; A L Beaudet; A E McCall; L A Duvick; L P Ranum; H Y Zoghbi
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

7.  Expression of apamin receptor in muscles of patients with myotonic muscular dystrophy.

Authors:  J F Renaud; C Desnuelle; H Schmid-Antomarchi; M Hugues; G Serratrice; M Lazdunski
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

8.  Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs.

Authors:  G Jansen; M Mahadevan; C Amemiya; N Wormskamp; B Segers; W Hendriks; K O'Hoy; S Baird; L Sabourin; G Lennon
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

9.  Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy.

Authors:  C Tsilfidis; A E MacKenzie; G Mettler; J Barceló; R G Korneluk
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

10.  Myotonic dystrophy kinase is a component of neuromuscular junctions.

Authors:  P F van der Ven; G Jansen; T H van Kuppevelt; M B Perryman; M Lupa; P W Dunne; H J ter Laak; P H Jap; J H Veerkamp; H F Epstein
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

View more
  1 in total

1.  Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin.

Authors:  J Salgado-Garrido; E Bragado-Nilsson; S Kandels-Lewis; B Séraphin
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.